Reuters logo
3 months ago
BRIEF-Nabriva Therapeutics reports Q1 loss per share $5.60
May 10, 2017 / 8:50 PM / 3 months ago

BRIEF-Nabriva Therapeutics reports Q1 loss per share $5.60

May 10 (Reuters) - Nabriva Therapeutics AG

* Nabriva Therapeutics reports first quarter 2017 financial results

* Q1 loss per share $5.60 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below